Adriaenssens AE, Biggs EK, Darwish T, Tadross J, Sukthankar T, Girish M, Polex-Wolf J, Lam BY, Zvetkova I, Pan W, et al
It can, with deliberate work
The study demonstrated MSMs ability to slow physical decline associated with aging joints
The American Diabetes Association (ADA) guidelines updated in 2023 recommend GLP-1 receptor agonists as a preferred treatment option for many patients with type 2 diabetes, particularly those with or at high risk for cardiovascular disease or kidney disease
A provider can help determine: Whether medication is appropriate for your health goals Which treatment option may work best for your body How to safely manage dosing and side effects How to track progress over time Personalized guidance helps ensure that treatment is both safe and effective